Skip to main content
SpringerLink
Log in

Effect of ghrelin and metoclopramide on prolactin secretion in normal women

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: Administration of ghrelin to women stimulates the secretion of PRL but the mechanism is not known. Aim: The aim of the study was to investigate the effect of the dopamine receptor blocker, metoclopramide, on ghrelin-induced PRL release. Subjects and methods: Ten healthy normally cycling women were studied in the midluteal phase of 4 menstrual cycles. A single dose of normal saline (cycle 1 ), ghrelin (1 μg/kg) (cycle 2), metoclopramide (20 mg) (cycle 3), and ghrelin plus metoclopramide (cycle 4) was given to the women iv. Blood samples in relation to the iv injection (time 0) were taken at -15, 0,15, 30, 45, 60, 75, 90, and 120 min. The response of PRL and GH was assessed. Results: Following ghrelin administration (cycles 2 and 4), plasma ghrelin and serum PRL and GH levels increased rapidly, peaking at 30 min (p<0.001). PRL was also increased after the injection of metoclopramide (p<0.001, cycle 3), but the increase was much greater than after the administration of ghrelin. The combination of ghrelin and metoclopramide stimulated PRL secretion to the same extent with metoclopramide alone. No changes in GH and PRL levels were seen after saline injection. Conclusions: These results demonstrate that the stimulating effect of ghrelin on PRL secretion is not additive with that of metoclopramide, although a dose range study might provide further information.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402: 656–60.

    Article  PubMed  CAS  Google Scholar 

  2. Soares JB, Leite-Moreira AF. Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides 2008, 29: 1255–70.

    Article  PubMed  CAS  Google Scholar 

  3. Takaya K, Ariyasu H, Kanamoto N, et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 2000, 85: 4908–11.

    Article  PubMed  CAS  Google Scholar 

  4. Hataya Y, Akamizu T, Takaya K, et al. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 2001, 86: 4552–5.

    Article  PubMed  CAS  Google Scholar 

  5. Villa P, Costantini B, Perri C, Suriano R, Ricciardi L, Lanzone A. Estro-progestin supplementation enhances the growth hormone secretory responsiveness to ghrelin infusion in postmenopausal women. Fertil Steril 2008, 89: 398–403.

    Article  PubMed  CAS  Google Scholar 

  6. Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE. Effect of ghrelin on gonadotrophin secretion in women during the menstrual cycle. Hum Reprod 2009, 24: 976–81.

    Article  PubMed  CAS  Google Scholar 

  7. Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE. Growth hormone and prolactin response to ghrelin during the normal menstrual cycle. Clin Endocrinol 2009, 71: 383–7.

    Article  CAS  Google Scholar 

  8. Arvat E, Maccario M, Di Vito L, et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001, 86: 1169–74.

    PubMed  CAS  Google Scholar 

  9. Schmid DA, Held K, Ising M, Uhr M, Weikel JC, Steiger A. Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology 2005, 30: 1187–92.

    Article  PubMed  CAS  Google Scholar 

  10. Fusco A, Bianchi A, Mancini A, et al. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome. J Endocrinol Invest 2007, 30; 948–56.

    Article  PubMed  CAS  Google Scholar 

  11. Alvarez-Castro, P, Isidro ML, Garcia-Buela J, et al. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Clin Endocrinol 2004, 61: 250–5.

    Article  CAS  Google Scholar 

  12. Guido M, Romualdi D, De Marinis L, et al. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin. Fertil Steril 2007, 88: 125–30.

    Article  PubMed  CAS  Google Scholar 

  13. Broglio F, Gianotti L, Destefanis S, et al. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol 2004, 60: 592–9.

    Article  CAS  Google Scholar 

  14. Fassino S, Daga GA, Mondelli V, et al. Hormonal and metabolic responses to acute ghrelin administration in patients with bulimia nervosa. Psychoneuroendocrinology 2005, 30: 534–40.

    Article  PubMed  CAS  Google Scholar 

  15. Kok P, Paulo RC, Cosma M, et al. Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women. J Clin Endocrinol Metab 2008, 93: 4020–6.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  16. Rubinfeld H, Hadani M, Taylor JE, et al. Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells. Eur J Endocrinol. 2004, 151: 787–95.

    Article  PubMed  CAS  Google Scholar 

  17. Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Anifandis G, Messinis IE. Blockage of ghrelin-induced prolactin secretion in women by bromocriptine. Fertil Steril 2010, 94: 1478–81.

    Article  PubMed  CAS  Google Scholar 

  18. Judd SJ, Lazarus L, Smythe G. Prolactin secretion by metoclopramide in man. J Clin Endocrinol Metab 1976, 43: 313–7.

    Article  PubMed  CAS  Google Scholar 

  19. Cunha-Filho JS, Gross JL, Vettori D, Dias EC, Passos EP. Growth hormone and prolactin secretion after metoclopramide administration (DA2 receptor blockade) in fertile women. Horm Metab Res 2001, 33: 536–9.

    Article  PubMed  CAS  Google Scholar 

  20. del Pozo E, Brownell J. Prolactin. I. Mechanisms of control, peripheral actions and modification by drugs. Horm Res 1979, 10: 143–74.

    Article  PubMed  Google Scholar 

  21. Reymond MJ, Porter JC. Involvement of hypothalamic dopamine in the regulation of prolactin secretion. Horm Res 1985, 22: 142–52.

    Article  PubMed  CAS  Google Scholar 

  22. Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 2001, 22: 724–63.

    Article  PubMed  CAS  Google Scholar 

  23. Hirvonen E, Ranta T, Seppala M. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine. J Clin Endocrinol Metab 1976, 42: 1024–30.

    Article  PubMed  CAS  Google Scholar 

  24. Andreassen B, Huth J, Tyson JE. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone. Am J Obstet Gynecol 1979, 135: 737–42.

    PubMed  CAS  Google Scholar 

  25. Kauppila A, Ylikorkala O. Effects of oral and intravenous TRH and metoclopramide on PRL and TSH secretion in women. Clin Endocrinol 1982, 17: 617–23.

    Article  CAS  Google Scholar 

  26. Veldhuis JD, Keenan DM, Iranmanesh A, Mielke K, Miles JM, Bowers CY. Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women. J Clin Endocrinol Metab 2006, 91: 3559–65.

    Article  PubMed  CAS  Google Scholar 

  27. Messinis IE, Lolis DE, Dalkalitsis N, Kanaris C, Souvatzoglou A. Effect of metoclopramide on maternal and fetal prolactin secretion during labor. Obstet Gynecol 1982, 60: 686–8.

    PubMed  CAS  Google Scholar 

  28. Login IS, Judd AM, Kuan SI, MacLeod RM. Role of calcium in dopaminergic regulation of TRH- and angiotensin II-stimulated prolactin release. Am J Physiol 1991, 260: E553–60.

    PubMed  CAS  Google Scholar 

  29. Cui ZJ, Gorelick FS, Dannies PS. Calcium/calmodulin-dependent protein kinase-II activation in rat pituitary cells in the presence of thyrotropin-releasing hormone and dopamine. Endocrinology 1994, 134: 2245–50.

    PubMed  CAS  Google Scholar 

  30. Martínez de la Escalera G, Guthrie J, Weiner RI. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway. Neuroendocrinology 1988, 47: 38–45.

    Article  PubMed  Google Scholar 

  31. Ho KY, Smythe GA, Lazarus L. The interaction of trh and dopaminergic mechanisms in the regulation of stimulated prolactin release in man. Clin Endocrinol (Oxf) 1985, 23: 7–16.

    Article  CAS  Google Scholar 

  32. Hanew K, Utsumi A, Sugawara A, Shimizu Y, Yoshinaga K. Simultaneous administration of TRH and sulpiride caused additive but not synergistic PRL responses in normal subjects. Endocrinol Jpn 1992, 39: 465–8.

    Article  PubMed  CAS  Google Scholar 

  33. Nishina Y, Takano K, Yasufuku-Takano J, Teramoto A, Fujita T. Mechanism of D(2) agonist-induced inhibition of GH secretion from human GH-secreting adenoma cells. Endocr J 2005, 52: 775–9.

    Article  PubMed  CAS  Google Scholar 

  34. Colao A, Filippella M, Pivonello R, Di Somma C, Faggiano A, Lombardi G. Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours. Eur J Endocrinol 2007, 156 (Suppl 1): S57–63.

    Article  PubMed  CAS  Google Scholar 

  35. Kok P, Roelfsema F, Frölich M, van Pelt J, Meinders AE, Pijl H. Short-term treatment with bromocriptine improves impaired circadian growth hormone secretion in obese premenopausal women. J Clin Endocrinol Metab 2008, 93: 3455–61.

    Article  PubMed  CAS  Google Scholar 

  36. Yang H, Dixit VD, Patel K, Vandanmagsar B, Collins G, Sun Y, Smith RG, Taub DD. Reduction in hypophyseal growth hormone and prolactin expression due to deficiency in ghrelin receptor signaling is associated with Pit-1 suppression: relevance to the immune system. Brain Behav Immun 2008, 22: 1138–45.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  37. Seki K, Nagata T. Effects of a dopamine antagonist (metoclopramide) on the release of LH, FSH, TSH and PRL in normal women throughout the menstrual cycle. Acta Endocrinol (Copenh) 1990, 122: 211–6.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Obstetrics and Gynaecology Medical School, University of Thessalia, 41110, Larissa, Greece

    C. I. Messini, K. Dafopoulos, N. Chalvatzas, G. Anifandis & I. E. Messinis MD, PhD

  2. Department of Nuclear Medicine, Medical School, University of Thessalia, Larissa, Greece

    P. Georgoulias

Authors
  1. C. I. Messini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Dafopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Chalvatzas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Georgoulias
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Anifandis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. E. Messinis MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. E. Messinis MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Messini, C.I., Dafopoulos, K., Chalvatzas, N. et al. Effect of ghrelin and metoclopramide on prolactin secretion in normal women. J Endocrinol Invest 34, 276–279 (2011). https://doi.org/10.1007/BF03347085

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347085

Key-words

Search

Navigation